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N-Methylcysteine-Mediated Total Chemical Synthesis of Ubiquitin Thioester
Solid-phase chemistry was carried out manually in syringes, equipped with teflon filters, purchased from Torviq or by using an automated peptide synthesizer (CS336X, CSBIO). If not differently described, all reactions were carried out at room temperature. Analytical HPLC was performed on a Thermo instrument (Spectra System p4000) using an analytical column (Jupiter 5 micron, C18, 300A 150 x 4.6 mm) and a flow rate of 1.2 mL/min. Preparative HPLC was performed on an ECOM instrument using a preparative Column (Jupiter 5 micron, C18, 300A, 250 x 10 mm) and a flow rate of 25 mL/min. DMF was purchased in biotech grade.
Commercial reagents were used without further purification. Resins, protected amino acids and HBTU were purchased from Novabiochem. Enzymatic cleavage of isopeptide: Purified peptide 8 was dissolved in 482 μL of assay buffer (50 mM Tris, 150 mM NaCl, 1 mM DTT, pH 7.5) to a final concentration of ~100 μM and reacted with recombinant human ubiquitin C-terminal hydrolase L3 (UCH-L3, Aldrich). 10 μg of UCH-L3 in 15.5 μL of assay buffer containing 50 mM Tris, 150 mM NaCl, 12 mM DTT, pH 8.0 was incubated for 20 min at 25 ºC. To the reduced UCH-L3 was then added 8 in 187 μL. The mixture was incubated for 12 h at 37 ºC, at which a complete hydrolysis was achieved. The reaction was analyzed using C-4 analytical RP-HPLC employing a gradient of 10-60% B for 30 min, in order to identify the hydrolysis products. 
